(Q38026774)

27 August 2017

title

Blastic leukaemias (AML): a biologist's view (English)

1 reference

27 August 2017

1 reference

Julio Roberto Cáceres-Cortés

series ordinal

1

1 reference

27 August 2017

publication date

1 May 2013

1 reference

Cell Biochemistry and Biophysics

27 August 2017

published in

1 reference

27 August 2017

volume

66

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

13-22

1 reference

27 August 2017

cites work

Acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

JAK and MPL mutations in myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Myelodysplasic syndromes: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Genetic abnormalities and challenges in the treatment of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Classification of acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Autocrine growth factors and leukaemic haemopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

What is the role of reduced-intensity transplantation in the treatment of older patients with AML?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

The colony-stimulating factors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Lack of KIT or FMS internal tandem duplications but co-expression with ligands in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

ras mutations in human leukemia and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Clinical implications of c-Kit mutations in acute myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Tyrphostins and other tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

A potent anti-carcinoma and anti-acute myeloblastic leukemia agent, AG490.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

On the nature of the tumor-initiating cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

CHIR-258: a potent inhibitor of FLT3 kinase in experimental tumor xenograft models of human acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N'-{4-(4-quinolyloxy)phenyl}ureas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Cells of origin in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

The cancer stem cell hypothesis: a work in progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Biology of normal and acute myeloid leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

mTOR links oncogenic signaling to tumor cell metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Autophagy delays apoptotic death in breast cancer cells following DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Stem cells in the etiology and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Deficiency in apoptotic effectors Bax and Bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Irregular arrays and randomization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Stem cells and the niche: a dynamic duo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Common and distinct features of cytokine effects on hematopoietic stem and progenitor cells revealed by dose-response surface analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Cytokine manipulation of primitive human hematopoietic cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Steel factor responsiveness regulates the high self-renewal phenotype of fetal hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Identification of a new intrinsically timed developmental checkpoint that reprograms key hematopoietic stem cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

The role of autophagy in cancer: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

Chapter 15 Signal-Dependent Control of Autophagy-Related Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9392-8

10.1007/S12013-012-9392-8

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1049582474

0 references

1 reference